Kimber D Lockhart 1 Life Healthcare Inc (ONEM) insider trading activity

Kimber D Lockhart is Chief Technology Officer of 1Life Healthcare Inc. Currently has a direct ownership of 70,434 shares of ONEM, which is worth approximately $0. The most recent transaction as insider was on Apr 21, 2021, when has been sold 30,000 shares (Common Stock) at a price of $41.39 per share, resulting in proceeds of $1,241,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.4K

0% 3M change

0% 12M change

Total Value Held $0

Kimber D Lockhart Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 21 2021	SELL Open market or private sale	$1,241,700 $41.39 p/Share	30,000 Reduced 29.87%	70,434 Common Stock
Apr 21 2021	BUY Exercise of conversion of derivative security	$238,800 $7.96 p/Share	30,000 Added 23.0%	100,434 Common Stock
Apr 07 2021	SELL Open market or private sale	$1,214,100 $40.47 p/Share	30,000 Reduced 29.87%	70,434 Common Stock
Apr 07 2021	BUY Exercise of conversion of derivative security	$130,800 $4.36 p/Share	30,000 Added 23.0%	100,434 Common Stock
Mar 17 2021	SELL Open market or private sale	$1,254,000 $41.8 p/Share	30,000 Reduced 29.87%	70,434 Common Stock
Mar 17 2021	BUY Exercise of conversion of derivative security	$130,800 $4.36 p/Share	30,000 Added 23.0%	100,434 Common Stock
Mar 03 2021	SELL Open market or private sale	$1,353,600 $45.12 p/Share	30,000 Reduced 29.87%	70,434 Common Stock
Mar 03 2021	BUY Exercise of conversion of derivative security	$130,800 $4.36 p/Share	30,000 Added 23.0%	100,434 Common Stock
Feb 17 2021	SELL Open market or private sale	$1,675,500 $55.85 p/Share	30,000 Reduced 29.87%	70,434 Common Stock
Feb 17 2021	BUY Exercise of conversion of derivative security	$130,800 $4.36 p/Share	30,000 Added 23.0%	100,434 Common Stock
Feb 03 2021	SELL Open market or private sale	$1,632,300 $54.41 p/Share	30,000 Reduced 29.87%	70,434 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$130,800 $4.36 p/Share	30,000 Added 23.0%	100,434 Common Stock
Jan 20 2021	SELL Open market or private sale	$1,566,000 $52.2 p/Share	30,000 Reduced 29.87%	70,434 Common Stock
Jan 20 2021	BUY Exercise of conversion of derivative security	$131,100 $4.37 p/Share	30,000 Added 23.0%	100,434 Common Stock
Jan 06 2021	SELL Open market or private sale	$1,294,200 $43.14 p/Share	30,000 Reduced 29.87%	70,434 Common Stock
Jan 06 2021	BUY Exercise of conversion of derivative security	$131,100 $4.37 p/Share	30,000 Added 23.0%	100,434 Common Stock
Dec 28 2020	BUY Exercise of conversion of derivative security	$151,914 $3.53 p/Share	43,035 Added 37.93%	70,434 Common Stock
Dec 16 2020	SELL Open market or private sale	$1,144,800 $38.16 p/Share	30,000 Reduced 52.27%	27,399 Common Stock
Dec 16 2020	BUY Exercise of conversion of derivative security	$131,100 $4.37 p/Share	30,000 Added 34.33%	57,399 Common Stock
Dec 03 2020	SELL Open market or private sale	$414,770 $35.15 p/Share	11,800 Reduced 30.1%	27,399 Common Stock
Dec 03 2020	BUY Exercise of conversion of derivative security	$51,566 $4.37 p/Share	11,800 Added 23.14%	39,199 Common Stock
Dec 02 2020	SELL Open market or private sale	$629,356 $34.58 p/Share	18,200 Reduced 39.91%	27,399 Common Stock
Dec 02 2020	BUY Exercise of conversion of derivative security	$79,534 $4.37 p/Share	18,200 Added 28.53%	45,599 Common Stock
Nov 20 2020	SELL Open market or private sale	$525,000 $35.0 p/Share	15,000 Reduced 28.65%	37,349 Common Stock
Nov 20 2020	BUY Exercise of conversion of derivative security	$65,550 $4.37 p/Share	15,000 Added 22.27%	52,349 Common Stock

Also insider at

NVTA

Invitae Corp Healthcare

Director

KDL